Selective Estrogen Receptor Modulators (SERMs) - A Potential Treatment for Psychotic Symptoms of Schizophrenia in Men?

Clinical trial NCT01481883 · COMPLETED

Trial details

NCT number: NCT01481883
Sponsor: The Alfred
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Schizophrenia Schizoaffective Disorder Schizophreniform Disorder

Start date: 2012-01-01
Primary completion: 2019-01-01
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.